Family Medicine Doctors in Heath, TX Accepting Medicare
7 Family Medicine doctors found. Showing 1 - 7
 Rana S Pascoe, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6435 S Fm 549 Ste 201, Heath, TX 75032 Phone: 214-771-3712 Fax: 214-771-3796 |
 Dr. David B. Lensch, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6435 S Fm 549, Suite 201, Heath, TX 75032 Phone: 972-771-9155 Fax: 972-771-2390 |
Dr. Robert Greg Maul, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6435 S Fm 549 Ste 204, Heath, TX 75032 Phone: 214-501-1410 |
Dr. John M Wiprud, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6435 S Fm 549, Suite 201, Heath, TX 75032 Phone: 972-771-9155 Fax: 972-771-2390 |
Mr. James Bernhardt Goodman, MD Family Medicine - Adult Medicine Medicare: Not Enrolled in Medicare Practice Location: 2505 Chantilly Ct, Heath, TX 75032 Phone: 972-771-0502 |
Vincent John Gonino, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6720 Horizon Rd, Heath, TX 75032 Phone: 469-402-2800 Fax: 469-402-0348 |
Dr. Jeffry F Adcock, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6435 S Fm 549, Suite 201, Heath, TX 75032 Phone: 972-771-9155 Fax: 972-771-2390 |
News Archive
PET imaging of cerebral cannabinoid CB1 receptors with [11C]JHU75528
A team of Johns Hopkins researchers developed a new radiotracer - a radioactive substance that can be traced in the body - to visualize and quantify the brain's cannabinoid receptors by positron emission tomography (PET).
Biogen's Multiple Sclerosis pill succeeds at a late phase clinical trial
Biogen Idec Inc. has reported success in a late stage clinical trial of its oral multiple sclerosis drug BG-12, a competitor's of Teva Pharmaceutical Industries' Laquinimod. A 240-milligram dose of BG-12 administered two or three times a day significantly reduced the proportion of patients who relapsed by 49% and 50%, respectively, after two years compared with a placebo.
Pregnant women transmit SARS-CoV-2 and vaccine-induced antibodies to fetus
Pregnant women are at high risk for severe COVID-19 infection and death. Yet, insufficient safety data on babies has led many guidelines to leave the decision-making and potential threats to future mothers. While the vaccine trials did not directly test pregnant women, more real-world data suggests the vaccine may provide immunity benefits to newborns through breastmilk.
Study finds no overall improvement in heart transplant waitlist after policy change
In March 2016, the Organ Procurement and Transplantation Network revised its criteria for prioritizing children awaiting heart transplantation in the U.S. with the intention of reducing the number of deaths on the waitlist, but a new study suggests unintended consequences.
Realignment with participants' interest important for future of genomic research
Obtaining consent for genetic studies can be an opportunity for researchers to foster respectful engagement with participants, not merely to mitigate legal risk. This shift is proposed in a policy forum appearing tomorrow, Jan. 21, in Science, the journal of the American Academy for the Advancement of Science.
› Verified 4 days ago
Family Medicine
Pediatrics
Emergency Medicine
Internal Medicine
Obstetrics & Gynecology